EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
Eagle Pharmaceuticals(EGRX) Newsfilter·2024-02-02 06:30调查与索赔 - Faruqi & Faruqi, LLP正在调查针对Eagle Pharmaceuticals, Inc.的潜在索赔[2] - 公司被指控违反联邦证券法，涉嫌发布虚假和/或误导性声明[4] - 公司股价在一系列负面消息后出现大幅下跌[5][7][8]